Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 25,000 shares at $19.66 ($491K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Scheduled sale ($491k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.66 | 4,500 | $88K | 18.0% |
| 2 | $19.66 | 8,000 | $157K | 32.0% |
| 3 | $19.66 | 4,500 | $88K | 18.0% |
| 4 | $19.66 | 8,000 | $157K | 32.0% |
| Total | $19.66 avg | 25,000 | $491K | 100% |
| Filing → |
| BCAX | SELL | 2026-07-10 | $833K | — | Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |